Atlas Trials

Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

Clinical trial NCT01736475 · COMPLETED

Trial details

NCT number
NCT01736475
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hemophilia A
Start date
2013-01-31
Primary completion
2014-07-17
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.